The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.
Continue Reading
A new drug delivery system has been developed that hides chemotherapy molecules inside fat cells that are quickly eaten up by hungry tumors. The method has been shown to be effective at targeting bone, colon and pancreatic cancers in animals, and human trials are proposed for the near future.
Continue Reading
Researchers have created a portable device they say can determine the efficacy of patient-specific cancer drugs with an accuracy of almost 96 percent. Teaming sensors with machine learning, the device provides rapid results, aiding the selection of better drugs while reducing potential side effects.
Continue Reading
Researchers at MIT have identified a surprising new dynamic drug duo to fight cancer, combining two classes that are already beginning to be widely used. Interestingly, the combo appears to work in a completely different way to what scientists previously expected.
Continue Reading
A study is reporting successful clinical trial results for a new orally administered iteration in a novel class of drugs designed to treat migraine, ahead of a potential FDA approval later this year. But some scientists are questioning how clinically useful these new migraine drugs actually are.
Continue Reading
In one of the biggest studies of its kind to date, researchers have found no evidence to suggest the legalization of marijuana results in an increase in youth use. In fact, the study points to a strange potential decrease in teen marijuana use following the implementation of recreational use laws.
Continue Reading
By guiding evolution, scientists have managed to manipulate micro-organisms into producing useful new drugs and materials, but it’s a time-consuming process. Now, UNC researchers have developed a new tool that speeds up the process in mammalian cells, creating new therapeutics in a matter of days.
Continue Reading
Researchers at the Technical University of Munich (TUM) have demonstrated a prototype of a drug that can release three active ingredients, at different times in sequence. The key to this unusual and useful ointment is artificial DNA, which breaks down at precise intervals.
Continue Reading
Humans are currently locked in an arms race against pathogenic bacteria – and we’re losing. Now scientists have identified the genes responsible for antibiotic resistance in a particularly dangerous superbug, and found a way to thwart them.
Continue Reading
Research led by the University of Arizona may have uncovered a new potential treatment target for tinnitus – not the ears but within the brain itself. The study suggests that neuroinflammation is to blame, and could be a new way to fix the problem.
Continue Reading
See the stories that matter in your inbox every morning